Ultra-long-acting TRT depot (Nebido / Aveed) injected every 10–14 weeks.
Typical dose range: 750–1000 mg
Frequency: Every 10–14 weeks
Route: Intramuscular (deep)
Half-life: ~33 days
Evidence level: Strong (FDA-approved)
Steady levels with quarterly dosing, but slow titration and risk of pulmonary oil microembolism mean clinic-administered protocols are typical.